Ligand gated ionotropic receptors are responsible for the fast neurotransmission in the brain and are the target of widely used drugs, such as anxiolytics, anticonvulsant and antidepressant, and of endogenously produced substances, e.g. hormones. In this review, the fast regulatory effects of thyroid hormones (THs, T3 and T4) on ligand gated ion channels will be analyzed and discussed. More precisely, the focus will be on receptors that mediate the majority of inhibitory and excitatory neurotransmission in the brain, respectively γ-aminobutyric acid (GABA) and glutamate ionotropic receptors.Brain is an important target of THs, as proved by profound alterations in its functionality related to hormonal imbalance. Indeed, dysthyroidism is often associated with several neuropsychiatric disorders that derive also from a dysfunction of GABAergic and glutamatergic neurotransmission. The molecular mechanisms responsible for these changes are not completely clarified yet. THs, through the binding of nuclear receptors, can modulate the expression of proteins directly or indirectly involved in neurotransmission; in addition, their non genomic fast modulation of ionotropic receptors mediating excitatory and inhibitory neurotransmission could also play an important role.THs modulate recombinant and native receptors activated by exogenous GABA or glutamate as well synaptic and extrasynaptic excitatory and inhibitory neurotransmission. These non genomic effects do not depend on protein phosphorylation or on the membrane integrin receptor αvβ3 activation.Keeping in mind that a local regulation of THs levels can occur in different brain regions the fast modulation of THs of synaptic activity could provide a rapid and efficacious control of the function of several brain circuitries.

“Non genomic mechanisms of thyroid hormones in Nongenomic effects of thyroid hormones.” / Puja, Giulia. - In: IMMUNOLOGY, ENDOCRINE & METABOLIC AGENTS IN MEDICINAL CHEMISTRY. - ISSN 1871-5222. - STAMPA. - 11:(2011), pp. 179-183. [10.2174/187152211796642756]

“Non genomic mechanisms of thyroid hormones in Nongenomic effects of thyroid hormones.”

PUJA, Giulia
2011

Abstract

Ligand gated ionotropic receptors are responsible for the fast neurotransmission in the brain and are the target of widely used drugs, such as anxiolytics, anticonvulsant and antidepressant, and of endogenously produced substances, e.g. hormones. In this review, the fast regulatory effects of thyroid hormones (THs, T3 and T4) on ligand gated ion channels will be analyzed and discussed. More precisely, the focus will be on receptors that mediate the majority of inhibitory and excitatory neurotransmission in the brain, respectively γ-aminobutyric acid (GABA) and glutamate ionotropic receptors.Brain is an important target of THs, as proved by profound alterations in its functionality related to hormonal imbalance. Indeed, dysthyroidism is often associated with several neuropsychiatric disorders that derive also from a dysfunction of GABAergic and glutamatergic neurotransmission. The molecular mechanisms responsible for these changes are not completely clarified yet. THs, through the binding of nuclear receptors, can modulate the expression of proteins directly or indirectly involved in neurotransmission; in addition, their non genomic fast modulation of ionotropic receptors mediating excitatory and inhibitory neurotransmission could also play an important role.THs modulate recombinant and native receptors activated by exogenous GABA or glutamate as well synaptic and extrasynaptic excitatory and inhibitory neurotransmission. These non genomic effects do not depend on protein phosphorylation or on the membrane integrin receptor αvβ3 activation.Keeping in mind that a local regulation of THs levels can occur in different brain regions the fast modulation of THs of synaptic activity could provide a rapid and efficacious control of the function of several brain circuitries.
2011
11
179
183
“Non genomic mechanisms of thyroid hormones in Nongenomic effects of thyroid hormones.” / Puja, Giulia. - In: IMMUNOLOGY, ENDOCRINE & METABOLIC AGENTS IN MEDICINAL CHEMISTRY. - ISSN 1871-5222. - STAMPA. - 11:(2011), pp. 179-183. [10.2174/187152211796642756]
Puja, Giulia
File in questo prodotto:
File Dimensione Formato  
Puia-IEMA 4th-2.pdf

Accesso riservato

Tipologia: Versione pubblicata dall'editore
Dimensione 961.88 kB
Formato Adobe PDF
961.88 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/742437
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 3
  • ???jsp.display-item.citation.isi??? ND
social impact